Samalin Investment Counsel, LLC Cocrystal Pharma, Inc. Transaction History

Samalin Investment Counsel, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$0.38 - $0.55 $380 - $550	-1,000 Closed	0 $0
Q2 2021 Aug 12, 2021	BUY	$1.08 - $2.14 $1,080 - $2,140	1,000 New	1,000 $1,000
Q1 2021 May 11, 2021	SELL	$1.3 - $2.35 $1,300 - $2,350	-1,000 Closed	0 $0
Q3 2020 Nov 10, 2020	BUY	$0.86 - $2.36 $860 - $2,360	1,000 New	1,000 $0
Q1 2020 May 04, 2020	SELL	$0.48 - $2.19 $480 - $2,190	-1,000 Closed	0 $0
Q4 2019 Feb 05, 2020	BUY	$0.39 - $2.05 $390 - $2,050	1,000 New	1,000 $0

Ticker COCP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 8,122,420
Market Cap $21.3M
Description
Cocrystal Pharma, Inc., a biotechnology company, focuses on the discovery and development of antiviral therapeutic treatments for serious and/or chronic viral diseases. It employs structure-based technologies to create antiviral drugs primarily to treat hepatitis C virus (HCV), influenza virus, coronavirus, and norovirus infections. The company ...

Get notified when there are updates to the investment portfolio of Samalin Investment Counsel, LLC, based on Form 13F filings with the SEC.

Stay updated on Samalin Investment Counsel, LLC with notifications on news.